Brief: Exagen Reports Qtrly Loss Per Share $0.48
May 11 (Reuters) - Exagen Inc XGN.O :
* EXAGEN INC. REPORTS FIRST QUARTER 2021 RESULTS
* SEES FY REVENUE $47 MILLION TO $49 MILLION
* Q1 REVENUE $10.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$10.5
MILLION
* FOR FULL YEAR 2021, EXAGEN REAFFIRMS ITS PRIOR GUIDANCE
AND
EXPECTS REVENUE TO BE IN RANGE OF $47 MILLION TO $49 MILLION
* QTRLY LOSS PER SHARE $0.48
Source text for Eikon: ID:nGNX10lpVs
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance